Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2025 Annual General and Special Meeting of Shareholders
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has announced its upcoming annual general and special meeting scheduled for August 8, 2025, at 1:00 p.m. Eastern Time. The meeting will be held virtually via live webcast.
The company reminds shareholders to cast their votes before the proxy voting deadline of August 6, 2025, at 1:00 p.m. Eastern Time. The Board of Directors recommends voting in favor of all director nominees and proposed resolutions. Shareholders can access meeting materials on Aurora's website and SEDAR+, with voting available online or by telephone through Laurel Hill Advisory Group.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), una delle principali aziende globali canadesi nel settore della cannabis medica, ha annunciato la sua prossima assemblea generale annuale e straordinaria, che si terrà il 8 agosto 2025 alle 13:00 ora orientale. L'incontro si svolgerà in modalità virtuale tramite webcast in diretta.
L'azienda ricorda agli azionisti di esprimere il proprio voto entro la scadenza per il voto per delega, fissata al 6 agosto 2025 alle 13:00 ora orientale. Il Consiglio di Amministrazione raccomanda di votare a favore di tutti i candidati alla direzione e delle risoluzioni proposte. Gli azionisti possono consultare i materiali della riunione sul sito web di Aurora e su SEDAR+, con la possibilità di votare online o telefonicamente tramite Laurel Hill Advisory Group.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), una destacada empresa canadiense líder en cannabis medicinal a nivel mundial, ha anunciado su próxima junta general anual y especial programada para el 8 de agosto de 2025 a la 1:00 p.m. hora del Este. La reunión se realizará de forma virtual a través de una transmisión en vivo.
La compañía recuerda a los accionistas que emitan sus votos antes de la fecha límite para el voto por poder, que es el 6 de agosto de 2025 a la 1:00 p.m. hora del Este. La Junta Directiva recomienda votar a favor de todos los candidatos a directores y las resoluciones propuestas. Los accionistas pueden acceder a los materiales de la reunión en el sitio web de Aurora y en SEDAR+, con la opción de votar en línea o por teléfono a través de Laurel Hill Advisory Group.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB)� 캐나다를 기반으로 � 세계적인 의료� 대마초 기업으로, 2025� 8� 8� 오후 1�(동부 표준�)� 예정� 연례 � 특별 주주총회� 발표했습니다. 회의� 라이� 웹캐스트� 통해 온라인으� 진행됩니�.
회사� 주주들에� 2025� 8� 6� 오후 1�(동부 표준�)까지 위임� 투표� 완료� 것을 당부합니�. 이사회는 모든 이사 후보와 제안� 결의안에 찬성 투표� 것을 권고합니�. 주주들은 Aurora 웹사이트와 SEDAR+에서 회의 자료� 확인� � 있으�, Laurel Hill Advisory Group� 통해 온라� 또는 전화� 투표� � 있습니다.
Aurora Cannabis (NASDAQ : ACB) (TSX : ACB), une entreprise canadienne de premier plan dans le domaine du cannabis médical à l'échelle mondiale, a annoncé la tenue de son assemblée générale annuelle et extraordinaire prévue le 8 août 2025 à 13h00, heure de l'Est. La réunion se tiendra virtuellement via un webinaire en direct.
La société rappelle aux actionnaires de bien vouloir voter avant la date limite du vote par procuration, fixée au 6 août 2025 à 13h00, heure de l'Est. Le conseil d'administration recommande de voter en faveur de tous les candidats au poste d'administrateur ainsi que des résolutions proposées. Les actionnaires peuvent consulter les documents de la réunion sur le site d'Aurora et sur SEDAR+, avec la possibilité de voter en ligne ou par téléphone via Laurel Hill Advisory Group.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), ein führendes globales medizinisches Cannabisunternehmen mit Sitz in Kanada, hat seine bevorstehende jährliche Haupt- und Sonderversammlung angekündigt, die für den 8. August 2025 um 13:00 Uhr Eastern Time geplant ist. Die Versammlung wird virtuell per Live-Webcast abgehalten.
Das Unternehmen erinnert die Aktionäre daran, ihre Stimmen vor der Frist für die Stimmrechtsvertretung am 6. August 2025 um 13:00 Uhr Eastern Time abzugeben. Der Vorstand empfiehlt, allen vorgeschlagenen Direktoren und Beschlüssen zuzustimmen. Die Aktionäre können die Sitzungsunterlagen auf der Website von Aurora und SEDAR+ einsehen und online oder telefonisch über die Laurel Hill Advisory Group abstimmen.
- None.
- None.
- Your vote is important no matter how many shares you own. Please vote today.
- Shareholders who have questions or need assistance with voting their shares should contact Aurora's strategic advisor and proxy solicitation agent, Laurel Hill Advisory Group, by telephone at 1-877-452-7184 or by email at [email protected].
Shareholders are advised to vote their shares well in advance of the proxy voting deadline of Wednesday, August 6, 2025 at 1:00 p.m. Eastern Time / 11:00 a.m. Mountain Time.
YOUR VOTE IS IMPORTANT NO MATTER HOW MANY SHARES YOU HOLD.
THE BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE FOR ALL DIRECTOR NOMINEES AND PROPOSED RESOLUTIONS
Shareholders are encouraged to read the Meeting materials, available on the Company's website at as well as under Aurora's profile on SEDAR+ (). In the interest of time, shareholders may vote online or by telephone in accordance with the voting instructions found on their form of proxy or voting instruction form.
Shareholder Questions & Voting Assistance
Shareholders who have any questions or require assistance with voting may contact the Aurora's proxy solicitation agent and shareholder communications advisor:
Laurel Hill Advisory Group
Toll Free: 1-877-452-7184 (for shareholders in
International: +1 416-304-0211 (for shareholders outside
By Email: [email protected]
About Aurora
Aurora is opening the world to cannabis, serving both the medical and consumer markets across
Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".
Forward Looking Information
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the Meeting.
These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods imported from
View original content to download multimedia:
SOURCE Aurora Cannabis Inc.